tradingkey.logo

New England Journal Of Medicine To Publish Results From Savara’S Phase 3 Impala-2 Clinical Trial In Autoimmune Pulmonary Alveolar Proteinosis

ReutersAug 20, 2025 9:26 PM

- Savara Inc SVRA.O:

  • NEW ENGLAND JOURNAL OF MEDICINE (NEJM) TO PUBLISH RESULTS FROM SAVARA’S PIVOTAL PHASE 3 IMPALA-2 CLINICAL TRIAL IN AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS (AUTOIMMUNE PAP)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

Tradingkey
KeyAI